XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment
Beginning balance (in shares) at Dec. 26, 2021     109,345,697      
Beginning balance at Dec. 26, 2021 $ 653,117 $ (4,944) $ 109 $ 1,129,224 $ (476,216) $ (4,944)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (90,156)       (90,156)  
Exercise of stock options (in shares) 560,610   560,610      
Exercise of stock options $ 2,927   $ 1 2,926    
Issuance of common stock related to restricted shares (in shares)     57,050      
Stock-based compensation expense 45,372     45,372    
Ending balance (in shares) at Jun. 26, 2022     109,963,357      
Ending balance at Jun. 26, 2022 606,316   $ 110 1,177,522 (571,316)  
Beginning balance (in shares) at Mar. 27, 2022     109,511,355      
Beginning balance at Mar. 27, 2022 621,535   $ 110 1,152,237 (530,812)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (40,504)       (40,504)  
Exercise of stock options (in shares)     407,452      
Exercise of stock options 2,078     2,078    
Issuance of common stock related to restricted shares (in shares)     44,550      
Stock-based compensation expense 23,207     23,207    
Ending balance (in shares) at Jun. 26, 2022     109,963,357      
Ending balance at Jun. 26, 2022 606,316   $ 110 1,177,522 (571,316)  
Beginning balance (in shares) at Dec. 25, 2022     111,132,993      
Beginning balance at Dec. 25, 2022 541,226   $ 111 1,212,716 (671,601)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (60,915)       (60,915)  
Exercise of stock options (in shares) 521,242   521,242      
Exercise of stock options $ 2,510   $ 1 2,509    
Issuance of common stock related to restricted shares (in shares)     298,778      
Shares repurchased for employee tax withholding     (6,559)      
Shares repurchased for employee tax withholding (164)     (164)    
Stock-based compensation expense 28,667     28,667    
Ending balance (in shares) at Jun. 25, 2023     111,946,454      
Ending balance at Jun. 25, 2023 511,324   $ 112 1,243,728 (732,516)  
Beginning balance (in shares) at Mar. 26, 2023     111,443,502      
Beginning balance at Mar. 26, 2023 522,557   $ 111 1,227,704 (705,258)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (27,258)       (27,258)  
Exercise of stock options (in shares)     360,278      
Exercise of stock options 1,743   $ 1 1,742    
Issuance of common stock related to restricted shares (in shares)     143,220      
Shares repurchased for employee tax withholding     (546)      
Shares repurchased for employee tax withholding (120)     (120)    
Stock-based compensation expense 14,402     14,402    
Ending balance (in shares) at Jun. 25, 2023     111,946,454      
Ending balance at Jun. 25, 2023 $ 511,324   $ 112 $ 1,243,728 $ (732,516)